Focus
FDA Approval
FDA Approves 1st T-Cell Therapy for Melanoma
The therapy was granted accelerated approval for its use in treating patients with metastatic and unremovable melanoma.
|
FDA Approves New Treatment for Metastatic Pancreatic Cancer
The new frontline therapy is the first in a decade intended to treat aggressive pancreatic adenocarcinoma.
|
FDA Approves 1st Medication for Severe Frostbite
The medication dilates blood vessels to prevent blood from clotting, lowering the risk of finger or toe amputation.
|
Survey Shows Doctors Have Limited Knowledge of FDA Approval Protocol
Over half of American doctors are under the impression the FDA approval process for new drugs and medical devices is more rigorous than it actually is.
|
FDA Approves First Treatment for Painful Non-Cancerous Tumors
The first drug to treat desmoid tumors shrank tumors in 41 percent of participants and improved quality of life with few side effects.
|
FDA Approves 1st T-Cell Therapy for Melanoma
The therapy was granted accelerated approval for its use in treating patients with metastatic and unremovable melanoma.
|
FDA Approves New Treatment for Metastatic Pancreatic Cancer
The new frontline therapy is the first in a decade intended to treat aggressive pancreatic adenocarcinoma.
|
FDA Approves 1st Medication for Severe Frostbite
The medication dilates blood vessels to prevent blood from clotting, lowering the risk of finger or toe amputation.
|
Survey Shows Doctors Have Limited Knowledge of FDA Approval Protocol
Over half of American doctors are under the impression the FDA approval process for new drugs and medical devices is more rigorous than it actually is.
|
FDA Approves First Treatment for Painful Non-Cancerous Tumors
The first drug to treat desmoid tumors shrank tumors in 41 percent of participants and improved quality of life with few side effects.
|